Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Therapeutic Efficacy of Intra-lesional Immunotherapy Against Recalcitrant Tinea Cruris & Corporis: a Pilot Study

NCT07312604 is registered in ClinicalTrials.gov with Abeer Mohamed Abdelaziz Elkholy as lead sponsor.

NCT NCT07312604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Therapeutic Efficacy of Intra-lesional Immunotherapy Against Recalcitrant Tinea Cruris & Corporis: a Pilot Study
Lead sponsor
Abeer Mohamed Abdelaziz Elkholy
Phase
Not applicable
Overall status
Recruiting
Start date
December 9, 2025
Completion date
March 9, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinea corporis, tinea cruris